Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1144: The Impact of Prosthesis-Patient Mismatch on Hemodynamic Valve Deterioration after Transcatheter Aortic Valve Replacement

Presenter: Revathy Sampath-Kumar

October 25, 2025

Presentation TCT 2024

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

Presenter: Tyler Andrews

October 29, 2024

Presentation TCT 2024

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Presenter: Yu Sato

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Presenter: Pablo Juan-Salvadores

October 27, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Presenter: Mazhed Kheyrbek

October 26, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Presenter: Davide Capodanno

September 26, 2019

Presentation TCT 2018

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

Presenter: James B. Hermiller Jr, Wilson Y. Szeto, Khalil Fattouch, Sameer Gafoor, Adam B. Greenbaum, Roger J. Laham, Ruediger S. Lange, Rashmi Yadav

September 24, 2018

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

Advertisement

TCT 1144: The Impact of Prosthesis-Patient Mismatch on Hemodynamic Valve Deterioration after Transcatheter Aortic Valve Replacement

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

A Modern Approach to Bioprosthetic Valve Deterioration and Failure: Emerging Data After TAVR

Case Presentation: Deterioration of LV Systolic Function/Worsened Heart Failure Despite Successful TMVR

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content